Lubrizol will exhibit at WHX Dubai, February 9–12, 2026, Booth #S13.B112, highlighting its commitment to accelerating medical device innovation worldwide.

As part of its global expansion, Lubrizol is introducing new contract manufacturing capabilities in India, including a state-of-the-art medical manufacturing site in Chennai, Tamil Nadu, scheduled to open mid-2026. 

This new facility in Chennai, Tamil Nadu, will produce high-quality medical tubing for neurovascular and cardiovascular applications, including balloon catheters and other devices for minimally invasive procedures. Leveraging Lubrizol’s advanced medical-grade thermoplastic polyurethane (TPU) and other biocompatible engineered polymers, the tubing produced is intended for minimally invasive device technologies, supporting applications in electrostimulation, cardiovascular, neurovascular, and beyond. Key capabilities include single and multi-lumen precision extrusion of TPU, Nylon, Pebax® and other engineered thermoplastics, tri layer tubing, balloon tubing, as well as braiding.

“We are strengthening our presence in India with strategic investments in local manufacturing, R&D, and technical capabilities,” said Mittal Shah, Business Head at Lubrizol. “These investments address our customers’ need for biocompatible, high-performance materials and advanced solutions that enable medical device innovation in India and globally.”

Visit Booth #S13.B112 at WHX Dubai to learn more about how Lubrizol can help you design, develop, and deliver next-generation medical devices. Contact us to discuss: Medical@Lubrizol.com.